Ikena Oncology
IKNA
$1.69
Share price
0.60%
Change (1 day)
-73.55%
Change (1 year)
Categories
Ikena Oncology (IKNA) - Cash on Hand
Cash on Hand as of March 2024 : $0.15 B
According to Ikena Oncology's latest financial reports the company has $0.15 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Ikena Oncology - Cash on Hand chart (from 2020 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.17 B | 11.8% |
| 2022-12-31 | $0.15 B | -32.41% |
| 2021-12-31 | $0.23 B | 42.91% |
| 2020-12-31 | $0.16 B | 97.96% |
| 2019-12-31 | $82.08 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.31 B | 101.32% | 🇺🇸 USA |